First Time Loading...

Enanta Pharmaceuticals Inc
NASDAQ:ENTA

Watchlist Manager
Enanta Pharmaceuticals Inc Logo
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Watchlist
Price: 15.17 USD 9.06% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

ENTA Price Targets Summary
Enanta Pharmaceuticals Inc

Wall Street analysts forecast ENTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENTA is 22.73 USD with a low forecast of 13.13 USD and a high forecast of 36.75 USD.

Lowest
Price Target
13.13 USD
13% Downside
Average
Price Target
22.73 USD
50% Upside
Highest
Price Target
36.75 USD
142% Upside
Enanta Pharmaceuticals Inc Competitors:
Price Targets
235980
MedPacto Inc
147% Upside
251120
Bio-FD&C Co Ltd
35% Upside
BIOCON
Biocon Ltd
6% Downside
BLRX
BioLine RX Ltd
80% Downside
MNKD
MannKind Corp
65% Upside
PYC
PYC Therapeutics Ltd
224% Upside
PHIL
Philogen SpA
34% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
1% Downside

Revenue
Forecast

Revenue Estimate
Enanta Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Enanta Pharmaceuticals Inc's revenue is -8%. The projected CAGR for the next 3 years is -1%.

-8%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Enanta Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Enanta Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENTA's stock price target?
Price Target
22.73 USD

According to Wall Street analysts, the average 1-year price target for ENTA is 22.73 USD with a low forecast of 13.13 USD and a high forecast of 36.75 USD.

What is Enanta Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for Enanta Pharmaceuticals Inc's revenue is -8%. The projected CAGR for the next 3 years is -1%.